Log In
Print this Print this

Alpha synuclein (SNCA)-PET imaging agent

  Manage Alerts
Collapse Summary General Information
Company AC Immune S.A.
DescriptionLigand for positron emission tomography (PET) of alpha synuclein (SNCA)
Molecular Target Alpha synuclein (SNCA)
Mechanism of ActionImaging agent
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentPreclinical
Standard IndicationNeurology, Diagnostic
Indication DetailsDiagnose Parkinson's disease (PD)
Regulatory Designation
PartnerBiogen Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today